We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$562M
AUM Growth
+$227M
Cap. Flow
+$212M
Cap. Flow %
37.82%
Top 10 Hldgs %
51.62%
Holding
194
New
19
Increased
129
Reduced
11
Closed
24
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIMT
151
DELISTED
Aimmune Therapeutics
AIMT
$271K 0.05%
12,472
+1,196
+11% +$24.5K
RARE icon
152
Ultragenyx Pharmaceutical
RARE
$2.65B
$269K 0.05%
3,972
+381
+11% +$29K
AGR
153
DELISTED
Avangrid, Inc.
AGR
$269K 0.05%
6,298
-3,000
-32% -$123K
CRBP icon
154
Corbus Pharmaceuticals
CRBP
$170M
$268K 0.05%
1,085
+104
+11% +$25.5K
INO icon
155
Inovio Pharmaceuticals
INO
$79.8M
$267K 0.05%
3,361
+322
+11% +$25.7K
MGNX icon
156
MacroGenics
MGNX
$235M
$263K 0.05%
14,128
+1,354
+11% +$26.1K
RDUS
157
DELISTED
Radius Health, Inc.
RDUS
$262K 0.05%
6,780
+650
+11% +$27.3K
LXRX icon
158
Lexicon Pharmaceuticals
LXRX
$1.02B
$260K 0.05%
18,150
+1,740
+11% +$25.8K
XLRN
159
DELISTED
Acceleron Pharma
XLRN
$257K 0.05%
9,701
+930
+11% +$24.5K
AGEN
160
Agenus
AGEN
$249M
$250K 0.04%
3,379
+324
+11% +$25.7K
PTCT icon
161
PTC Therapeutics
PTCT
$6.37B
$223K 0.04%
22,699
+2,176
+11% +$26.3K
KA
162
DELISTED
Kineta, Inc. Common Stock
KA
$209K 0.04%
191
+18
+10% +$33.3K
FPRX
163
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$203K 0.04%
5,628
+540
+11% +$23.8K
NERV icon
164
Minerva Neurosciences
NERV
$188M
$169K 0.03%
2,601
+249
+11% +$19.3K
CEMP
165
DELISTED
Cempra, Inc.
CEMP
$149K 0.03%
39,698
+3,805
+11% +$13.2K
EPR.PRC icon
166
EPR Properties 5.75% Series C Preferred Shares
EPR.PRC
$151M
$145K 0.03%
+5,040
New +$147K
UPW icon
167
ProShares Ultra Utilities
UPW
$18.8M
$136K 0.02%
12,400
-30,144
-71% -$311K
VVC
168
DELISTED
Vectren Corporation
VVC
$129K 0.02%
+2,200
New +$122K
EPR.PRE icon
169
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$114M
$116K 0.02%
+3,230
New +$117K
DIG icon
170
ProShares Ultra Energy
DIG
$71.1M
-9,363
Closed -$510K
DVY icon
171
iShares Select Dividend ETF
DVY
$24B
-19,735
Closed -$1.75M
HE icon
172
Hawaiian Electric Industries
HE
$2.33B
-11,050
Closed -$365K
IDU icon
173
iShares US Utilities ETF
IDU
$1.41B
-36,134
Closed -$2.2M
IGM icon
174
iShares Expanded Tech Sector ETF
IGM
$9.94B
-119,802
Closed -$2.47M
IWM icon
175
iShares Russell 2000 ETF
IWM
$80.9B
-8,030
Closed -$1.08M

Similar funds

Virtus ETF Advisers's Q1 2017 Portfolio in Review

As of Q1 2017, Virtus ETF Advisers held 194 positions worth $562M, up 68% from $335M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Virtus ETF Advisers deployed $212M of net new capital in Q1 2017, opening 19 new positions and adding to 129 existing holdings. Its largest new stake was Kinder Morgan: 272,117 shares worth $5.92M.

By sector, the portfolio is most concentrated in Energy at 70% of assets, up from 57% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $20.3M trimmed.

  • Virtus ETF Advisers's largest Q1 2017 buy was Kinder Morgan: 272,117 shares worth $5.92M.
  • Virtus ETF Advisers added most to iShares 0-1 Year Treasury Bond ETF in Q1 2017, an estimated $22.2M increase.
  • Virtus ETF Advisers's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.3M.
  • Virtus ETF Advisers fully exited iShares Expanded Tech Sector ETF in Q1 2017, selling an estimated $2.47M.
  • Virtus ETF Advisers's ten largest holdings make up 52% of its $562M portfolio in Q1 2017.
  • Virtus ETF Advisers opened 19 new positions and closed 24 in Q1 2017.
  • Virtus ETF Advisers's portfolio value rose 68% quarter-over-quarter to $562M.

Based on Virtus ETF Advisers's 13F filing for Q1 2017, filed 15 May 2017.